Catalpol antagonizes LPS-mediated inflammation and promotes osteoblast differentiation through the miR-124-3p/DNMT3b/TRAF6 axis
Acta Histochemica · 2024-01 · 126 (1) · 152118
DOI: 10.1016/j.acthis.2023.152118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Histochemica, 2024-01. Verfasst von Pan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The People's Hospital of Liaoning Province, Shenyang 110016, Liaoning, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Osteoporosis, Iridoid Glucosides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Dysregulated inflammation and osteoblast differentiation are implicated in osteoporosis. Exploring the activity of catalpol in inflammation and osteoblast differentiation deepens the understanding of osteoporosis pathogenesis. METHODS: LPS was used to treated hFOB1.19 cells to induce inflammation and repress osteoblast differentiation. FOB1.19 cells were induced in osteoblast differentiation medium and treated with LPS and catalpol. Cell viability was assessed using CCK-8. ALP and Alizarin red S staining were conducted for analyzing osteoblast differentiation. The levels of IL-1β, TNF-α and IL-6 were examined by ELISA. The methylation of TRAF6 promoter was examined through MS-PCR. The binding of miR-124-3p to DNMT3b and DNMT3b to TRAF6 promoter was determined with dual luciferase reporter and ChIP assays. RESULTS: LPS enhanced secretion of inflammatory cytokines and suppressed osteoblast differentiation. MiR-124-3p and TRAF6 were upregulated and DNMT3b was downregulated in LPS-induced hFOB1.19 cells. Catalpol protected hFOB1.19 cells against LPS via inhibiting inflammation and promoting osteoblast differentiation. MiR-124-3p targeted DNMT3b, and its overexpression abrogated catalpol-mediated protection in LPS-treated hFOB1.19 cells. In addition, DNMT3b methylated TRAF6 promoter to restrain its expression. Catalpol exerted protective effects through suppression of the miR-124-3p/DNMT3b/TRAF6 axis in hFOB1.19 cells. CONCLUSION: Catalpol antagonizes LPS-mediated inflammation and suppressive osteoblast differentiation via controlling the miR-124-3p/DNMT3b/TRAF6 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The People's Hospital of Liaoning Province, Shenyang 110016, Liaoning, People's Republic of China.
- Department of Orthopaedics, The People's Hospital of Liaoning Province, Shenyang 110016, Liaoning, People's Republic of China. Electronic address: drbai0313@163.com.
Zitieren
APA
Zhang, P., Feng, Q., Chen, W., & Bai, X. (2024). Catalpol antagonizes LPS-mediated inflammation and promotes osteoblast differentiation through the miR-124-3p/DNMT3b/TRAF6 axis. Acta Histochemica, 126(1), 152118. https://doi.org/10.1016/j.acthis.2023.152118
Vancouver
Zhang P, Feng Q, Chen W, Bai X. Catalpol antagonizes LPS-mediated inflammation and promotes osteoblast differentiation through the miR-124-3p/DNMT3b/TRAF6 axis. Acta Histochemica. 2024;126(1):152118. doi:10.1016/j.acthis.2023.152118
BibTeX
@article{Zhang2024,
author = {Zhang, Pan and Feng, Qun and Chen, Wenxiao and Bai, Xizhuang},
title = {Catalpol antagonizes LPS-mediated inflammation and promotes osteoblast differentiation through the miR-124-3p/DNMT3b/TRAF6 axis},
journal = {Acta Histochemica},
year = {2024},
volume = {126},
number = {1},
pages = {152118},
doi = {10.1016/j.acthis.2023.152118}
}
EUVIMED